NIH PAR · NIAMS · R01
PAR-24-280: Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.
- NOFO number
- PAR-24-280
- Type
- PAR
- Activity code
- R01
- Primary institute
- NIAMS · National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Clinical trials
- Not Allowed
- Posted
- Dec 9, 2024
- Opens
- Feb 4, 2025
- Expires
- Nov 3, 2026
PAR-24-280 due dates
1 application due date remains before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| March 04, 2025 | March 04, 2025 | Not Applicable | July 2025 | October 2025 | December 2025 |
| July 02, 2025 | July 02, 2025 | Not Applicable | November 2025 | January 2026 | April 2026 |
| November 04, 2025 | November 04, 2025 | Not Applicable | March 2026 | May 2026 | July 2026 |
| March 04, 2026 | March 04, 2026 | Not Applicable | July 2026 | October 2026 | December 2026 |
| July 02, 2026 | July 02, 2026 | Not Applicable | November 2026 | January 2027 | April 2027 |
| November 02, 2026 | November 02, 2026 | Not Applicable | March 2027 | May 2027 | July 2027 |
Projects funded under PAR-24-280
NIH RePORTER lists 3 projects funded under PAR-24-280 in FY2022–FY2026, with $647K in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
3
Distinct projects, FY2022–FY2026
New awards
3
Type 1 (new project) award records
NIH funding
$647K
Award dollars under PAR-24-280, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 3 | 3 | $647K |
Institutions with the most funding
- Rutgers Biomedical and Health Sciences$237K · 1 project
- UT Southwestern Medical Center$222K · 1 project
- Johns Hopkins University$187K · 1 project
Funding institutes
- NIAMS$647K · 3
Activity codes funded
- R013 records
Most recent new awards
- Establishing and Validating Outcome Measures for Craniofacial Morphea Across the Lifespan (opens NIH RePORTER)
UT Southwestern Medical Center · 1R01AR088597-01 · NIAMS · Notice Sep 17, 2026
$222KR01
- Biochemical and Imaging Biomarkers for Fracture Prediction in Duchenne Muscular Dystrophy (opens NIH RePORTER)
Johns Hopkins University · 1R01AR085874-01A1 · NIAMS · Notice Jul 21, 2026
$187KR01
- Study to Probe & Assess Registry-Claims Linkage for Juvenile Idiopathic Arthritis (SPARCLe-JIA) (opens NIH RePORTER)
Rutgers Biomedical and Health Sciences · 1R01AR085879-01A1 · NIAMS · Notice May 29, 2026
$237KR01
What its predecessor PAR-24-036 funded
PAR-24-280 reissues PAR-24-036. Its funding history is the best guide to who wins under this program: 8 projects and $3.6M in FY2022–FY2026.
Projects funded
8
Distinct projects, FY2022–FY2026
New awards
8
Type 1 (new project) award records
NIH funding
$3.6M
Award dollars under PAR-24-036, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 9 | 8 | $2.2M |
| FY2026 | 7 | 0 | $1.4M |
Institutions with the most funding
- University of Pennsylvania$543K · 1 project
- University of Maryland Baltimore$499K · 1 project
- Yale University$487K · 1 project
- Hospital for Special Surgery$474K · 1 project
- University of California, San Francisco$443K · 1 project
- University of California at Davis$434K · 1 project
- University of Alabama at Birmingham$427K · 1 project
- Boston University Medical Campus$339K · 1 project
Funding institutes
- NIAMS$3.6M · 16
Activity codes funded
- R0116 records
Most recent new awards
- Personalized Prediction of Atopic Dermatitis Disease Course Across Diverse Settings (opens NIH RePORTER)
University of California, San Francisco · 1R01AR085315-01A1 · NIAMS · Notice Sep 17, 2025
$244KR01
- Assessment of Treatment Variability for Pelvic Ring Fragility Fractures (Pelvis ATV) (opens NIH RePORTER)
University of Maryland Baltimore · 1R01AR086467-01 · NIAMS · Notice Sep 15, 2025
$485KR01
- Circulating cell free tumor DNA (ctDNA) in patients with immune checkpoint inhibitor associated inflammatory arthritis (ICI-IA): developing a biomarker to assess immunosuppressive drug safety (opens NIH RePORTER)
Hospital for Special Surgery · 1R01AR085258-01A1 · NIAMS · Notice Sep 8, 2025
$267KR01
- Validating Novel Outcomes to Enable Systemic Sclerosis Calcinosis Cutis Clinical Trials (opens NIH RePORTER)
Yale University · 1R01AR085316-01A1 · NIAMS · Notice Aug 29, 2025
$249KR01
- Gout Epidemiology in Chronic Kidney Disease: Transition to End-stage Kidney Disease and Impact of Renal Transplant (opens NIH RePORTER)
University of Alabama at Birmingham · 1R01AR085886-01 · NIAMS · Notice Jul 10, 2025
$241KR01
- Assessing spatial frequency domain imaging as an objective quantification of longitudinal skin changes in scleroderma (opens NIH RePORTER)
Boston University Medical Campus · 1R01AR085317-01 · NIAMS · Notice Apr 2, 2025
$174KR01
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-24-280. Contact the program officer at the institute that fits your research before applying.
- NIAMS · National Institute of Arthritis and Musculoskeletal and Skin Diseases
- none
Related notices
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Notices of Special Interest (NOSIs)
NIH has attached 2 NOSIs to PAR-24-280; none are active now. A NOSI flags a topic an institute wants to fund through this NOFO.
Award terms
- Application types allowed
- NewResubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Direct costs are limited to 475,000 over the four-year period exclusive of consortium/subcontractual Facilities and Administrative F&A) costs] with no more than 250,000 in any single year.
- Project period
- The scope of the proposed project should determine the project period. The maximum project period is four years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-24-036.
Other open NOFOs for R01
- PAR-27-075CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)NIAMS · next due Oct 5, 2027
- PAR-25-379Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)NIDA · next due Oct 21, 2026
- PAR-25-322Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)OD · next due Jan 26, 2027
- PA-25-301NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)NIH · next due Feb 5, 2027
- PA-25-305NIH Research Project Grant (Parent R01 Clinical Trial Required)NIH · next due Feb 5, 2027
- PAR-25-144Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)NCI · next due Feb 5, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.